Paquin, Ryan S.
Fischer, Ryan
Mansfield, Carol
Mange, Brennan
Beaverson, Katherine
Ganot, Annie
Martin, Amy Strong
Morris, Carl
Rensch, Colin
Ricotti, Valeria
Russo, Leo J.
Sadosky, Alesia
Smith, Edward C.
Peay, Holly L. http://orcid.org/0000-0002-3053-7453
Funding for this research was provided by:
Parent Project Muscular Dystrophy (N/A)
Article History
Received: 27 November 2018
Accepted: 17 April 2019
First Online: 9 May 2019
Authors’ information
: Not applicable.
: The study protocol received IRB review and approval from RTI International’s Committee for the Protection of Human Subjects.
: Not Applicable.
: RP– Declares no conflict of interest.RF– Full-time employee of Parent Project Muscular Dystrophy, which receives funding from Solid Bioscience and Pfizer in support of preference research programs.CM (1)– Declares no conflict of interest.BM – Declares no conflict of interest.KB – Full-time employee of Pfizer Inc. with stock holdings related to employment.AG – Employee and co-founder of Sold Biosciences, with stock holdings related to employment.AM – Declares no conflict of interest.CM (2)– Employee of Solid Biosciences and former employee of Pfizer, with stock holdings related to employment.CR – Declares no conflict of interest.VR – Employee of Solid Biosciences with stock holdings related to employment.LR – Full-time employee of Pfizer Inc. with stock holdings related to employment.AS – Full-time employee of Pfizer Inc. with stock holdings related to employment.ECS – Receives salary support from Pfizer Inc. for role as PI on a gene therapy trial.HP – Declares no conflict of interest.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.